The signaling pathway for GAD1 mutations was predominantly associated with tumor protein 53 (TP53); GAD1 promoter showed higher methylation in patients with TP53 mutated in prostate cancer (Fig. 4K). The gene discussed is GAD1; the disease is Familial prostate cancer.